CH617681A5 - - Google Patents

Download PDF

Info

Publication number
CH617681A5
CH617681A5 CH793075A CH793075A CH617681A5 CH 617681 A5 CH617681 A5 CH 617681A5 CH 793075 A CH793075 A CH 793075A CH 793075 A CH793075 A CH 793075A CH 617681 A5 CH617681 A5 CH 617681A5
Authority
CH
Switzerland
Prior art keywords
acid
formula
preparations
imidazolyl
active ingredient
Prior art date
Application number
CH793075A
Other languages
German (de)
English (en)
Inventor
Wolfgang Dr Kraemer
Karl Heinz Dr Buechel
Manfred Dr Plempel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CH617681A5 publication Critical patent/CH617681A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH793075A 1974-06-20 1975-06-18 CH617681A5 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2429514A DE2429514A1 (de) 1974-06-20 1974-06-20 Eckige klammer auf 1-imidazolyl-(1) eckige klammer zu- eckige klammer auf 1-(4'-(4''-chlorphenyl)-phenoxy eckige klammer zu-3,3-dimethyl-butan-2-on und seine salze, ein verfahren zu ihrer herstellung als arzneimittel

Publications (1)

Publication Number Publication Date
CH617681A5 true CH617681A5 (el) 1980-06-13

Family

ID=5918461

Family Applications (1)

Application Number Title Priority Date Filing Date
CH793075A CH617681A5 (el) 1974-06-20 1975-06-18

Country Status (26)

Country Link
US (1) US4000299A (el)
JP (1) JPS5817467B2 (el)
AR (1) AR205467A1 (el)
AT (1) AT340411B (el)
BE (1) BE830414A (el)
BG (1) BG23215A3 (el)
CA (1) CA1048511A (el)
CH (1) CH617681A5 (el)
DD (1) DD121940A5 (el)
DE (1) DE2429514A1 (el)
DK (1) DK137643C (el)
EG (1) EG11798A (el)
ES (1) ES438718A1 (el)
FI (1) FI751819A (el)
FR (1) FR2275205A1 (el)
GB (1) GB1466020A (el)
IE (1) IE41168B1 (el)
IL (1) IL47501A (el)
IN (1) IN140954B (el)
LU (1) LU72762A1 (el)
NL (1) NL7507327A (el)
NO (1) NO139784C (el)
PH (1) PH11696A (el)
PL (1) PL94280B1 (el)
SE (1) SE7507015L (el)
ZA (1) ZA753935B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2430039C2 (de) * 1974-06-22 1983-11-10 Bayer Ag, 5090 Leverkusen Climbazol in kosmetischen Mitteln
DE2455954A1 (de) * 1974-11-27 1976-08-12 Bayer Ag Diaryloxy-imidazolyl-o,n-acetale, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
PT66803B (en) * 1976-07-20 1978-12-20 Bayer Ag Process for preparing a fungicidal composition containing halogenated 1-azolyl-butane derivatives and their phisiologically suitable salts
DE2635665A1 (de) * 1976-08-07 1978-02-09 Bayer Ag Antimikrobielle mittel
DE2713777C3 (de) * 1977-03-29 1979-10-31 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von l-Azolyl-33-dimethyl-l-phenoxy-butan-2-onen
DE2816818A1 (de) * 1978-04-18 1979-10-31 Bayer Ag Optisch aktive 1-aethyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2105490C3 (de) * 1971-02-05 1979-06-13 Bayer Ag, 5090 Leverkusen 1 -Imidazolylketonderivate

Also Published As

Publication number Publication date
FI751819A (el) 1975-12-21
DK137643B (da) 1978-04-10
FR2275205B1 (el) 1978-10-06
SE7507015L (sv) 1975-12-22
IL47501A (en) 1978-06-15
FR2275205A1 (fr) 1976-01-16
US4000299A (en) 1976-12-28
BG23215A3 (el) 1977-07-12
NO139784C (no) 1979-05-09
IE41168L (en) 1975-12-20
DE2429514A1 (de) 1976-01-15
IE41168B1 (en) 1979-11-07
ES438718A1 (es) 1977-03-16
CA1048511A (en) 1979-02-13
IN140954B (el) 1977-01-08
DK278375A (da) 1975-12-21
ZA753935B (en) 1976-06-30
AR205467A1 (es) 1976-05-07
EG11798A (en) 1977-12-31
NL7507327A (nl) 1975-12-23
AT340411B (de) 1977-12-12
IL47501A0 (en) 1975-08-31
JPS5113770A (en) 1976-02-03
BE830414A (fr) 1975-12-19
PL94280B1 (el) 1977-07-30
GB1466020A (en) 1977-03-02
NO752016L (el) 1975-12-23
DK137643C (da) 1978-09-18
JPS5817467B2 (ja) 1983-04-07
NO139784B (no) 1979-01-29
LU72762A1 (el) 1976-04-13
DD121940A5 (el) 1976-09-05
PH11696A (en) 1978-05-24
AU8222275A (en) 1976-12-23
ATA467275A (de) 1977-04-15

Similar Documents

Publication Publication Date Title
EP0011769B1 (de) Hydroxyethyl-azole, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
EP0011768B1 (de) Hydroxypropyl-triazole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2333355C2 (de) Antimikrobielle Mittel
EP0003796B1 (de) Substituierte Diphenyl-imidazolyl-methane, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
EP0036153A1 (de) 1,1-Diphenyl-2-(1,2,4-triazol-1-yl)-äthan-1-ole als Antimykotika
EP0023614B1 (de) Antimykotische Mittel, die Imidazolylenolether umfassen, ihre Herstellung und ihre Verwendung
CH617681A5 (el)
EP0083750B1 (de) Antimykotische Azolyl-butanole
DE2632601A1 (de) Antimikrobielle mittel
EP0011770B1 (de) Fluorenyl-azolylmethyl-carbinole, Verfahren zu ihrer Herstellung, Arzneimittel, die diese Verbindungen enthalten und Verfahren zur Herstellung dieser Arzneimittel
DE2628421A1 (de) Antimikrobielle mittel
EP0022969B1 (de) Antimykotische Mittel, die Azolyl-alkenole enthalten und ihre Herstellung
EP0031883B1 (de) Antimikrobielle Mittel enthaltend Hydroxybutylimidazol-Derivate
DE3012770A1 (de) Biphenylyl-azolylethan-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0041615B1 (de) Verwendung von Imidazolyl-vinyl-ketonen und-carbinolen als antimikrobielle Mittel
DE2213863C3 (de) Disubstituierte Triphenylmethylimidazole, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
EP0039814B1 (de) Imidazolyl-indeno-thiophene, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
CH620683A5 (el)
DE2824690A1 (de) Substituierte imidazolyl-thiazolyl- methane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CH617682A5 (en) Process for the preparation of novel 1-imidazol-1-yl-2-(4'-(4''-chlorophenyl)phenoxy-4,4-dimethylpentan-3-on e and its salts
DE2850057A1 (de) Diastereomeres 1-(4-chlorphenoxy)- 1-(1-imidazolyl)-3,3-dimethyl-2-butanol, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel
DE2742175A1 (de) Antimikrobielle mittel
DE3314548A1 (de) Antimykotische mittel
DE2358592A1 (de) Antimikrobielle mittel
DE2630252C3 (de) Verwendung von Imidazol-1-yl-(4-phenoxyphenyl)-(pyridin-2-yl)phenylmethan bei der lokalen Bekämpfung von Dermatomykosen

Legal Events

Date Code Title Description
PL Patent ceased